Nasal Obstruction With Oxymetazoline and Corticosteroids

Description

This study aims to examine the efficacy and safety of commination oxymetazoline/intranasal steroids for long-term management of chronic nasal obstruction that is recalcitrant to the current standard of care. The investigators hypothesize that combination treatment with oxymetazoline and intranasal corticosteroid spray will provide a larger reduction in nasal obstruction than intranasal corticosteroid alone for patients suffering from chronic nasal obstruction, and there will not be occurrences of rhinitis medicamentosa.

Conditions

Nasal Obstruction

Talk to us

Study Overview

On this page

Study Details

Study overview

This study aims to examine the efficacy and safety of commination oxymetazoline/intranasal steroids for long-term management of chronic nasal obstruction that is recalcitrant to the current standard of care. The investigators hypothesize that combination treatment with oxymetazoline and intranasal corticosteroid spray will provide a larger reduction in nasal obstruction than intranasal corticosteroid alone for patients suffering from chronic nasal obstruction, and there will not be occurrences of rhinitis medicamentosa.

Nasal Obstruction Randomized Trial With Oxymetazoline and Corticosteroids

Nasal Obstruction With Oxymetazoline and Corticosteroids

Condition
Nasal Obstruction
Intervention / Treatment

-

Contacts and Locations

Saint Louis

Washington University, Saint Louis, Missouri, United States, 63110

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. males and females ages 18 years or older
  • 2. have a history of nasal obstruction
  • 3. have failed a trial of topical steroids (that included at least 1 month of daily use)
  • 4. ability to read, write, and understand English
  • 5. either do not desire surgery or are poor surgical candidates due to medical comorbidities.
  • 6. Patients who have had prior use of oxymetazoline or other nasal decongestants are eligible for the study but must have stopped usage 4 weeks prior to randomization.
  • 1. Must be willing to stop using any other nasal sprays, besides saline, and oral decongestants.
  • 1. Any history of sinonasal mass/tumor
  • 2. Any history of nasal polyps
  • 3. a known history of chronic sinusitis
  • 4. an allergy to oxymetazoline
  • 5. or who have any medical contraindication to oxymetazoline use, such as pulmonary hypertension.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Washington University School of Medicine,

Nyssa F Farrell, MD, PRINCIPAL_INVESTIGATOR, Washington University School of Medicine

Study Record Dates

2025-07-30